Depression among Medicare members is not a hidden problem. It is an undertreated one. Roughly 20% of adults over 65 experience depression or anxiety, and the majority go undiagnosed. For Medicare Advantage plans, that gap has been a quality concern for years. Starting with the 2027 measurement year, and reflected in 2029 Star Ratings, it becomes a scoring performance problem too.

CMS has finalized a new Part C Depression Screening and Follow-Up measure requiring MA plans to demonstrate that members are screened for clinical depression using a validated, age-appropriate standardized tool. Under the related clinical quality measure framework, the screening must occur within 14 days of a qualifying visit, results must be interpreted, and members who screen positive must have a documented follow-up plan within 2 calendar days. CMS will score plans on both the percentage of members screened and the percentage of positive screens that received follow-up, averaging the two rates for the final Star Rating.

That is not how traditional clinical workflows are built.

What the Measure Exposes

For most plans, this timeline will reveal a structural gap. Clinicians are under pressure during annual wellness visits. Post-visit follow-up workflows are often manual and inconsistently executed. And for members who are already hard to reach, initiating a behavioral health touchpoint within days of a positive screen is not something most plans have the infrastructure to do reliably at scale.

As Reed Smith's analysis of the final rule notes, CMS will display the depression screening rate and the positive-screen follow-up rate separately before averaging them. Plans will have clear visibility into where their gaps are. So will CMS.

This measure also does not exist in isolation. CMS simultaneously removed 11 administrative process measures from the Star Ratings framework while adding this behavioral health measure — a deliberate rebalancing that increases the relative weight of every remaining measure. Plans that were floating on process compliance no longer have that cushion. The depression screening measure is the first behavioral-health-specific Star Rating in the program's history. It will not be the last.

The members most likely to screen positive are also the hardest to reach through conventional outreach — isolated, homebound, and unlikely to respond to a call or complete a mailed survey. As we explored in a prior post, socially isolated older adults generate significantly more ED visits than those with active social connections. The conditions driving that utilization are exactly what this measure is designed to catch upstream.

Where Televeda Fits

Televeda already engages thousands of Medicare members between clinical visits through virtual programming, community classes, and live care coordination, across fitness, wellness, brain health, and peer support. That existing relationship is what makes the 14-day window workable.

Because Televeda operates in the space between visits, we can embed a validated digital screening tool directly into a member's engagement touchpoint in the days before their HRA or annual wellness visit. The screening happens on the member's terms, in a familiar environment, facilitated by Televeda's live care coordinators. That staff-assisted framework satisfies the interpretation and facilitation requirements the measure is built around.

When a PHQ-9 score comes back elevated, Televeda does not queue it for later review. It triggers immediate coordinator intervention. The member is already in an active relationship with a trusted person on our platform. The follow-up documentation does not wait for a clinic to open. It happens within the window the measure requires.

Members are not meeting a care coordinator for the first time when a screening is needed. They already know who Televeda is. That trust is the infrastructure most plans are currently missing.

For plans already using Televeda to improve member engagement and address social determinants of health, this workflow is an extension of what already exists. For plans that are not, the alternative is a 14-day window that opens and closes at the pace of a clinical calendar, with no reliable fallback once the appointment ends.

The Documentation Trail

Satisfying a CMS measure is not just about delivering the intervention. It is about documenting it in a way that survives audit. Televeda's data reporting infrastructure tracks screening completion, score interpretation, coordinator contact, and follow-up plan documentation with timestamps — so plans are not reconstructing that record from disconnected clinical notes and outreach logs after the fact.

Televeda's health plan partnerships are built around exactly this kind of pre-clinical infrastructure: moving quality strategy upstream, into the spaces where members actually spend their time, before the clinical encounter creates the pressure.

The 2027 measurement year is closer than it looks. If your plan is thinking through the depression screening measure now, let's talk.

Televeda is a HIPAA and NIST-compliant social health platform with a mission to alleviate social isolation, loneliness, and suicide risk among older adults and underserved communities. Televeda has reached over 800,000 lives across all 50 US states through partnerships with government agencies, health plans, and community organizations. Book a call with our team.

Sources

• CMS Final Rule Fact Sheet — CY 2027 Medicare Advantage and Part D (April 2026)
• Reed Smith — CMS Makes Structural Changes to Star Ratings System
• Becker's Hospital Review — CMS Finalizes 2027 MA and Part D Rule: 10 Notes
• NCQA — HEDIS Depression Screening and Follow-Up (DSF-E)
• CMS MIPS Quality Measure #134 — Screening for Depression and Follow-Up Plan
• Crowell & Moring — CMS Finalizes CY 2027 MA Rule: Key Implications for Plan Sponsors